Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis
Sign Up to like & getrecommendations! Published in 2019 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2019.0047
Abstract: Key Points Question Is bariatric surgery cost-effective in patients with nonalcoholic steatohepatitis and compensated cirrhosis? Findings In this simulation model study, laparoscopic sleeve gastrectomy had an incremental cost-effectiveness ratio of $66 119 per quality-adjusted life-year in… read more here.
Keywords: nonalcoholic steatohepatitis; cirrhosis; bariatric surgery; patients nonalcoholic ... See more keywords
Cardiovascular Outcomes and Mortality After Bariatric Surgery in Patients With Nonalcoholic Fatty Liver Disease and Obesity
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.7188
Abstract: Key Points Question Is bariatric surgery associated with the incidence of major adverse cardiovascular events or all-cause of mortality among patients with nonalcoholic fatty liver disease (NAFLD) and obesity? Findings In this cohort study of… read more here.
Keywords: nonalcoholic fatty; patients nonalcoholic; surgery; mortality ... See more keywords
Letter to the Editor: Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Steatohepatitis Cirrhosis and Diabetes: Insufficient for Individual Management
Sign Up to like & getrecommendations! Published in 2020 at "Hepatology"
DOI: 10.1002/hep.31100
Abstract: We read with interest the article by Ju Dong Yang et al.(1) The study demonstrated that diabetes is associated with an increased risk of hepatocellular carcinoma (HCC) in patients with nonalcoholic steatohepatitis (NASH) cirrhosis and… read more here.
Keywords: hepatocellular carcinoma; risk; patients nonalcoholic; nonalcoholic steatohepatitis ... See more keywords
Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-019-00785-6
Abstract: Background and ObjectiveSodium glucose co-transporter 2 inhibitors increase urinary glucose excretion and reduce visceral adiposity and body weight, but their efficacy on patients with nonalcoholic fatty liver disease has not been sufficiently investigated. The aim… read more here.
Keywords: glucose transporter; mass; patients nonalcoholic; nonalcoholic fatty ... See more keywords
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.
Sign Up to like & getrecommendations! Published in 2018 at "Gastroenterology"
DOI: 10.1053/j.gastro.2018.07.027
Abstract: BACKGROUND & AIMS De novo lipogenesis is increased in livers of patients with nonalcoholic steatohepatitis (NASH). Acetyl-coenzyme carboxylase catalyzes the rate-limiting step in this process. We evaluated the safety and efficacy of GS-0976, an inhibitor… read more here.
Keywords: hepatic steatosis; fibrosis; liver; given 0976 ... See more keywords
Association between small dense LDL levels and hepatic fibrosis in patients with nonalcoholic fatty liver disease
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000030527
Abstract: While patients with nonalcoholic fatty liver disease (NAFLD) continue to increase worldwide, few hematological biomarkers are helpful. This study examined the potential of small dense low density lipoprotein (sdLDL) as a noninvasive biomarker for NAFLD… read more here.
Keywords: patients nonalcoholic; liver; hepatic fibrosis; sdldl ... See more keywords
Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Diabetes Research"
DOI: 10.1155/2023/2044090
Abstract: Objective The aim of study was to evaluate the effect and safety of pioglitazone-metformin combined treatment in the newly diagnosed type 2 diabetes patients with nonalcoholic fatty liver disease. Methods A total of 120 newly… read more here.
Keywords: patients nonalcoholic; liver; fatty liver; newly diagnosed ... See more keywords
Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease.
Sign Up to like & getrecommendations! Published in 2021 at "Revista da Associacao Medica Brasileira"
DOI: 10.1590/1806-9282.20201016
Abstract: OBJECTIVE To evaluate the association between muscle mass depletion and compromising of the cell membrane integrity and clinical-anthropometric characteristics in patients with nonalcoholic fatty liver disease. METHODS This observational study evaluated waist circumference, body mass… read more here.
Keywords: mass; muscle mass; patients nonalcoholic; nonalcoholic fatty ... See more keywords
Effect of illness uncertainty on alanine transaminase levels and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease
Sign Up to like & getrecommendations! Published in 2022 at "Nagoya Journal of Medical Science"
DOI: 10.18999/nagjms.84.4.857
Abstract: ABSTRACT Patients with nonalcoholic fatty liver disease (NAFLD) have illness uncertainty. The purpose of this longitudinal study was to investigate the effect of the degree of illness uncertainty in patients with NAFLD on liver function… read more here.
Keywords: nonalcoholic fatty; patients nonalcoholic; illness uncertainty; fatty liver ... See more keywords
Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis
Sign Up to like & getrecommendations! Published in 2017 at "Nutrients"
DOI: 10.3390/nu9111220
Abstract: Nonalcoholic fatty liver disease (NAFLD) is a serious liver disorder associated with the accumulation of fat and inflammation. The objective of this study was to determine the gut microbiota composition that might influence the progression… read more here.
Keywords: fatty liver; gut microbiota; mice; patients nonalcoholic ... See more keywords
FEATURES OF INTESTINAL MICROBIOTA IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: EFFECTS ON MARKERS OF INFLAMMATION AND HEPATIC STEATOSIS.
Sign Up to like & getrecommendations! Published in 2022 at "Wiadomosci lekarskie"
DOI: 10.36740/wlek202203108
Abstract: OBJECTIVE The aim: To study the state of the intestinal microbiota (ІМ) in patients with Nonalcoholic fatty liver disease (NAFLD) and to determine changes in its composition at the level of basic phylotypes. PATIENTS AND… read more here.
Keywords: nonalcoholic fatty; microbiota patients; intestinal microbiota; patients nonalcoholic ... See more keywords